home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Exploiting bacteriophages for bioscience, biotechnology and medicine

 
  June 19, 2013  
     
 
Euroscicon, United Kingdom
Thursday, 23 January 2014


Bacteriophages (phages) are arguably the most abundant biological entities on the planet. They play crucial roles in driving the adaptive evolution of their bacterial hosts, and achieve this both through the predator)prey roles of the phage)bacterium interaction and through the adaptive impacts of lysogeny and lysogenic conversion.  Bacteriophages are the source of many biochemical reagents and technologies, indispensible for modern molecular biology.  Furthermore, phages are being exploited in other areas of biotechnology, including diagnostics, prophylaxis and other aspects of food microbiology. In recent years there has been a growing interest in developing phages for therapeutic purposes (phage therapy) as natural alternatives to antibiotics. The inexorable rise in the incidence of antibiotic resistance in bacterial pathogens, coupled with the disappointingly low rate of emergence of new, clinically useful antibiotics, has refocused attention on the potential utility of phages for treating human and animal disease. Examples of the roles of phages in fundamental biological research and in medical and industrial biotechnologies will be discussed at this meeting

 
 
Organized by: Euroscicon
Invited Speakers:
Professor Kerry Chester, UCL Cancer Institute, Paul O'Gorman Building, United Kingdom

Dr Amin Hajitou, Imperial College Faculty of Medicine, UK

Professor Colin Hill, University College Cork, Ireland
 
Professor David Gally, The Roslin Institute, University of Edinburgh

Dr John McCafferty, University of Cambridge, UK 

Dr Brian Reavy,  The James Hutton Institute, Scotland UK

Dr Darren Smith, Senior Lecturer in Biology, Northumbria University, UK 

 

 
Deadline for Abstracts: October 10th 2013
 
Registration:

A late registration fee applies after Oct 20th 2013

After this time the fees double, so make sure you register early!

E-mail: enquiries@euroscicon.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.